跳转至内容
Merck
CN

SML4033

BI-3812

≥98% (HPLC)

别名:

1-[5-Chloro-4-({8-methoxy-1-methyl-3-[(methylcarbamoyl)methoxy]-2-oxo-1,2-dihydroquinolin-6-yl}amino)pyrimidin-2-yl]-N,N-dimethylpiperidine-4-carboxamide, 1-(5-Chloro-4-((8-methoxy-1-methyl-3-(2-(methylamino)-2-oxoethoxy)-2-oxo-1,2-dihydroquinolin-6-yl)amino)pyrimidin-2-yl)-N,N-dimethylpiperidine-4-carboxamide, 8-(5-Chloro-2-(4-(dimethylamino-formyl)-piperidin-1-yl)-pyrimidin-4-ylamino)-10-methoxy-2-methyl-4-(2-methylamino-2-oxo-ethoxy)-2-aza-bicyclo[4.4.0]deca-1(6),4,7,9-tetraen-3-one, BI 3812, BI3812

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C26H32ClN7O5
化学文摘社编号:
分子量:
558.03
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C1C(OCC(NC)=O)=CC2=C(N1C)C(OC)=CC(NC3=NC(N4CCC(CC4)C(N(C)C)=O)=NC=C3Cl)=C2

Biochem/physiol Actions

Potent and selective BCL6 inhibitor that targets BTB domain with high-affinity.

BI-3812 is a potent and selective BCL6 inhibitor that targets BTB domain with high-affinity (IC50 ≤3 nM by ULight assay) that inhibits BCL6-dependent proliferation in a dose-depenent manner (typical dosing range 0.04 - 3 µM). Unlike BI-3802, BI-3812 does not induce BCL6 proteasomal degradation.


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库